First Horizon Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

First Horizon Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.73K	Sell	58 -1,174	-95%	-$52.2K	﹤0.01%	1977
2025 Q1	$54.4K	Buy	1,232 +49	+4%	+$2.26K	﹤0.01%	892
2024 Q4	$42.7K	Hold	1,183	–	–	﹤0.01%	1019
2024 Q3	$37.9K	Hold	1,183	–	–	﹤0.01%	1107
2024 Q2	$44.6K	Buy	1,183 +383	+48%	+$16.1K	﹤0.01%	971
2024 Q1	$39.4K	Sell	800 -67	-8%	-$3.1K	﹤0.01%	1071
2023 Q4	$31.6K	Sell	867 -23	-3%	-$600	﹤0.01%	1138
2023 Q3	$20.6K	Buy	890 +44	+5%	+$1.2K	﹤0.01%	1246
2023 Q2	$22.2K	Hold	846	–	–	﹤0.01%	1229
2023 Q1	$21.8K	Buy	846 +2	+0.2%	+$58	﹤0.01%	1235
2022 Q4	$22K	Sell	844 -77	-8%	-$1.9K	﹤0.01%	1221
2022 Q3	$26K	Buy	921 +162	+21%	+$4.64K	﹤0.01%	1129
2022 Q2	$17K	Buy	759 +751	+9,388%	+$27.5K	﹤0.01%	1360
2022 Q1	$0	Sell	8 -435	-98%	-$24.9K	﹤0.01%	2254
2021 Q4	$27K	Buy	443 +206	+87%	+$13.6K	﹤0.01%	1177
2021 Q3	$14K	Buy	+237	New	+$18.3K	﹤0.01%	1412

Other funds holding SWTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

First Horizon Advisors's SWTX Position: Q2 2025 in Review

First Horizon Advisors reduced its SpringWorks Therapeutics (SWTX) stake by 95% in Q2 2025, selling an estimated $52.2K and leaving 58 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1977.

First Horizon Advisors first reported a position in SWTX in Q3 2021 and has held it in 16 quarters since. The position peaked at $54.4K in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

First Horizon Advisors held 58 shares of SpringWorks Therapeutics worth $2.73K as of Q2 2025.
First Horizon Advisors sold 1,174 SpringWorks Therapeutics shares in Q2 2025, an estimated $52.2K.
SpringWorks Therapeutics made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1977 holding.
First Horizon Advisors first reported a position in SpringWorks Therapeutics in Q3 2021 and has held it in 16 quarters since.
First Horizon Advisors's SpringWorks Therapeutics position peaked at $54.4K in Q1 2025.
222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.